Next due
20 OCTGSTR-3B · Summary return · Sep 2026in 4 days 21 OCTTax Audit Report · Form 3CA/3CB · AY 2026-27 · extended from 30 Sepin 5 days 30 OCTAOC-4 · Financial statements · FY 2025-26in 14 days 7 NOVTDS / TCS deposit · Deducted in Oct 2026in 22 days 11 NOVGSTR-1 · Outward supplies · Oct 2026in 26 days 15 NOVPF & ESI · Contributions · Oct 2026in 30 days 21 NOVITR filing · Audit cases · AY 2026-27 · extended from 31 Octin 36 days 29 NOVMGT-7 / 7A · Annual return · FY 2025-26in 44 days
All due dates

Ind AS 38 — Intangible Assets

Ind AS 38 prescribes the recognition, measurement and amortisation of intangible assets, including the strict distinction between research and development expenditure.

Published
Updated
Reading time
4 min
Views
49
Questions
6 answered
  • Expert Reviewed
  • Medium Complexity
Topic
Accounting Standards & Bookkeeping
Published
August 26, 2026
Last updated
Aug 26, 2026
Reading time
4 min
0:00
Last updated: August 2026Verified against: Government sources

Overview

Ind AS 38, notified under the Companies (Ind AS) Rules, 2015, governs assets such as patents, licences, software, copyrights and acquired customer relationships. Its central tension is between the reality that intangibles increasingly drive corporate value and the risk of recognising uncertain, internally generated "assets" that cannot be reliably measured. The standard resolves this with demanding recognition criteria.

Definition and Recognition

An intangible asset is an identifiable non-monetary asset without physical substance that the entity controls and from which future economic benefits are expected. "Identifiable" requires it to be separable (capable of being sold or licensed independently) or to arise from contractual or legal rights. Recognition requires that future economic benefits are probable and that the cost can be measured reliably.

Scope

Ind AS 38 excludes intangibles covered by other standards — financial assets (Ind AS 109), exploration and evaluation assets, goodwill acquired in a business combination (Ind AS 103), intangibles held for sale (Ind AS 105), leases within Ind AS 116, and deferred tax assets (Ind AS 12).

Research versus Development

This distinction is the practical heart of the standard:

PhaseTreatment
Research (investigating for new knowledge)Always expensed as incurred
Development (applying research before commercial use)Capitalised only if all six criteria are met

Development costs are capitalised only when the entity can demonstrate: technical feasibility of completion; intention to complete and use or sell; ability to use or sell; how the asset will generate probable future economic benefits; availability of adequate technical, financial and other resources; and ability to measure reliably the expenditure attributable during development.

Internally Generated Intangibles

Internally generated goodwill, brands, mastheads, publishing titles, customer lists and items similar in substance are not recognised, because their cost cannot be reliably separated from the cost of developing the business as a whole. This is a frequent point of correction on Ind AS transition, where entities may have capitalised brand-building spend.

Measurement and Amortisation

After recognition, an entity applies either the cost model (cost less accumulated amortisation and impairment) or, rarely, the revaluation model — permitted only where an active market exists. An intangible with a finite useful life is amortised systematically over that life (usually straight-line), with the residual value normally assumed to be zero. An intangible with an indefinite useful life is not amortised but is tested for impairment annually and whenever there is an indicator.

Worked Example

A company spends ₹40,00,000 on a research phase and, once technical feasibility is established, ₹1,20,00,000 on development of a new software product meeting all six criteria. The ₹40,00,000 research spend is expensed. The ₹1,20,00,000 development spend is capitalised as an intangible asset. With an estimated useful life of six years, annual amortisation is ₹1,20,00,000 ÷ 6 = ₹20,00,000, charged to profit or loss from the date the software is available for use.

Key Differences from AS 26

The recognition criteria mirror the earlier AS 26, but Ind AS 38 permits an indefinite useful life (with annual impairment testing rather than amortisation), allows a revaluation model where an active market exists, and requires disclosure of the useful lives or amortisation rates and a reconciliation of carrying amounts. AS 26 presumed a maximum useful life of ten years in many cases.

Related Guides

Quick recapKey facts & short answers

Key Facts About Ind AS 38 Intangible

  • Applies in: All states across India, under the relevant central law.
  • Mode: Mostly online via the official government portal.
  • Typical timeline: Ranges from a few days to a few weeks depending on the case.
  • Non-compliance: May attract penalties, interest or late fees.
  • Expert help: TaxClue completes the entire process end to end for you.

What makes an item an intangible asset under Ind AS 38?

An identifiable non-monetary asset without physical substance that the entity controls and from which future economic benefits are expected. "Identifiable" means it is separable or arises from contractual or legal rights. It is recognised only if those benefits are probable and cost can be measured reliably.

How are research and development costs treated differently?

Research expenditure is always expensed as incurred. Development expenditure is capitalised only if the entity can demonstrate technical feasibility, intention and ability to complete and use or sell, probable future benefits, availability of resources, and reliable measurement of cost.

An audit goes quickly when the schedules are ready before the auditor asks.

— TaxClue Accounts & Audit Desk

Ind AS 38 Intangible: a key compliance topic in Indian tax and corporate law that businesses and individuals must understand to remain compliant.

Related Services & Guides

Was this article helpful?
About the author
13,350 articles
Vikas Sharma Verified expert Tax & Compliance Expert

Experienced in company registration, GST, trademark, and compliance. Helping Indian businesses stay compliant.

Last reviewed:

Disclaimer: This article is for general informational purposes only and does not constitute professional tax, legal or financial advice. Laws, rates and due dates change and can vary by individual case — always verify with the relevant government source (e.g. mca.gov.in, incometax.gov.in) or consult a qualified professional before acting. TaxClue accepts no liability for decisions taken based on this content.

People also ask

Questions, answered

Short, direct answers to the 6 questions readers ask most on this topic.

An identifiable non-monetary asset without physical substance that the entity controls and from which future economic benefits are expected. "Identifiable" means it is separable or arises from contractual or legal rights. It is recognised only if those benefits are probable and cost can be measured reliably.

Research expenditure is always expensed as incurred. Development expenditure is capitalised only if the entity can demonstrate technical feasibility, intention and ability to complete and use or sell, probable future benefits, availability of resources, and reliable measurement of cost.

No. Internally generated goodwill, brands, mastheads, publishing titles and customer lists are not recognised because their cost cannot be distinguished from the cost of developing the business as a whole.

Intangibles with a finite useful life are amortised on a systematic basis over that life, usually straight-line, and tested for impairment when indicators exist. Intangibles with an indefinite useful life are not amortised but tested for impairment annually.

Only if there is an active market for it, which is rare for intangibles. Most intangibles are carried under the cost model — cost less accumulated amortisation and impairment.

The recognition criteria are similar, but Ind AS 38 permits indefinite useful lives (with annual impairment testing instead of amortisation) and allows the revaluation model where an active market exists — options AS 26 did not provide.